Dana Aftab - Feb 15, 2023 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
CSO/EVP Disc & Trans Research
Signature
/s/ Nina Ayer, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Feb 15, 2023
Transactions value $
-$27,644
Form type
4
Date filed
2/17/2023, 08:39 PM
Previous filing
Jan 9, 2023
Next filing
Mar 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Tax liability -$27.6K -1.53K -0.43% $18.08 351K Feb 15, 2023 Direct F1, F2
holding EXEL Common Stock 5.84K Feb 15, 2023 By 401(k) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on December 15, 2021.
F2 Includes 210,090 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F3 Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 14, 2023.